Quality and Standards in Dietary Supplements by
Dr. Raymond
Chang, M.D., F.A.C.P.
A dietary supplement can be defined as anything that is not a drug
nor a food and can be consumed as an adjunct or addition to the
diet. This expansive American concept of "dietary supplement is a
confusing one, since it generally encompasses vitamins, herbs,
functional foods, nutraceuticals, minerals, and combinations of the
above
1. These categories are
imprecise and not mutually exclusive. An herb may be a food in some
cultures and can certainly contain vitamins, minerals, and other
bioactive ingredients. A food (eg, garlic), on the other hand, may
also be a supplement if extracted and presented in a pill or capsule
form.
Prevalence and Forms of Dietary Supplements
There is a bewildering array of supplements in the health-food
stores. Adding to the Confusion of defining supplements is the issue
of quality control and standardization. It is difficult to sift
through the thousands of different supplements currently on the
market, let alone choose among the many different brands, strengths,
and formulations of similar supplements. Such confusion in
definitions and products calls for enhanced standardization and
quality control.
The supplements industry is a large and rapidly growing business
2. One source estimates
gross revenues of $6 billion in the US alone
3. Since there are many
patients and consumers using supplements, practitioners need to know
with some degree of reliability their indications, dosages, side
effects, interactions, and contraindications. One major impediment
to advances in this area is a general lack of standardization and
quality control, in part because the Federal Food, Drug, and
Cosmetic Act as amended by the Dietary Supplement Health and
Education Act of 1994 (DSHEA) does not specifically require
standardization or quality control in the manufacturing process
beyond requiring supplements to be safe, clean, and wholesome 4.
First steps toward guaranteeing some consistency in ultimate product
function or content would be implementation of production and
material standards for supplements parallel to the United States
Pharmacopeia (USP) for pharmaceuticals, the Inter- ¡¤national
Standards Organization (ISO) series for industry, or Good
Manufacturing Practices (GAP)') for manufacturing. This is
particularly important so researchers can compare results of
studies, practitioners can rationally apply and recommend products,
and consumers can make intelligent choices of products.
Simple Moleculars versus Complex Biomasses
In essence, all supplements can be considered either "simple
moleculars" or "complex biomasses." A simple molecular supplement is
a vitamin, a mineral, or a single pure molecular substance such as
melatonin or Coenzyme Q 10. Complex biomass supplements are natural
animal or plant derivatives such as gingko, ginseng, thymus, or
cartilage. The complex biomasses are characterized by multiple
ingredient compounds, the contents and functions of which generally
vary based on multiple factors.
For example, the active ingredient of a plant-derived material may
depend on its location in the plant (leaf, stem, root, etc), the
season in which it is harvested, the lighting condition of its
growth, soil conditions, latitude, and so forth
5. A wine made from a
certain variety of grapes (a complex biomass) can taste different
from year to year and from place to place depending on climate and
geography. Other factors that affect the final product include the
extraction method (eg, water, alcohol, or glycerol) and formulation
(eg, tablet, capsule, or elixir) as well as pharmacokinetic issues
such as absorption, bioavailability metabolism, and excretion
(half-life).
Obviously, standardization is much more difficult with complex
biomasses than with simple moleculars. Such standardization is
dismally lacking in the self-regulated and profit-driven health
supplement industry.
Standardization
Standardization can be implemented at four levels: a) the species of
the animal or plant (ie genetics), b) the precise growth conditions
or definition of habitat, c) the extraction or formulation process,
and d) the product itself. Standardization of a product itself is
meant to be the manufacturer's or a regulatory agency's assurance of
the product's content or function. But currently neither federal nor
state governments mandate even such minimal requirements as routine
and repeated assay for heavy metal or bacterial contamination of
supplements.
Specifically, we can achieve content standardization of a product by
specifying a certain minimal amount of a key marker content (eg, 24
percent gingko bioflavonoids for gingko biloba products) as
determined by chromatography or other assay methods. We can achieve
function standardization with bioassays (eg, the chick
chorioallantoic membrane test for antiangiogenesis in shark's
cartilage 6). Furthermore, good
manufacturing practices should be mandatory. Standards should be set
and claims examined for packaging and labeling.
Ultimately, the efficacy of supplements In various clinical states
will have to be demonstrated in human clinical trials, and safety
should be guaranteed by improved and strictly enforced quality
controls in materials and manufacturing. Consumers, health care
providers, the health supplement industry, and the government will
need to work together to define the standards and systematically
examine all supplements in the interest of the public.
References
|
1.
|
I. See new section 201(ff)(1) of the FDC Act,21 USC §321(ff)(1).
|
|
2.
|
Sloan AE,Stiedemann MK. Guaranteed success: How to make products
consumers really want. f Nutraceut Funct & Med Foods.
1997;1:61-82.
|
|
3.
|
Reynolds RD. Vitamin supplements: current controversies. 7 Am
Coll Nutr. 1994; 1 3(2):1 18-126
|
|
4. |
Pub. Law 103~-417; 108 Stat. 4325-4335; 103rd Congress, 2d Sess.
(Oct. 25, 1994).
|
|
5. |
Vagujfalvi D.The most important substances in medicinal plants.
Modifying effects of external factors and treatments Herba
Hungarica. 1967; 6(3)175-199.
|
|
6. |
Lee A, Langer R. Shark cartilage contains inhibitor of tumor
angiogenesis. Science. 1983; 221:1185-1187.
|